Relmada Therapeutics Inc. (RLMD) Stock Continues Downward Trend Despite Promising Top-line Data from REL-1017 Study
Relmada Therapeutics Inc. (RLMD) stock prices were down 3.26% some time after market trading commenced on July 27th, 2021, bringing the price per share down to USD$24.30 early on in the trading day. Positive REL-1017 Topline Data July 27th 2021 announced the top-line results of the human abuse potential study with REL-1017, the company’s lead […]